News und Analysen
3 Healthcare Stocks for Your Radar
The healthcare sector is one the most exciting and volatile industries out there, with clinical trial results and administrative changes having the potential to make or break so many companies.....
3 Arguments for and Against Legalizing Marijuana
There's arguably no industry in the U.S. that's growing at a faster, more consistent pace than legal marijuana. Marijuana Business Daily's latest report, "Marijuana Business Factbook 2017,"....
5 Must-Read Quotes for Robotic Surgery Investors
Something big just happened in the robotic surgical industry. Last week, a small company called TransEnterix (NYSEMKT: TRXC) won FDA approval for its Senhance Robotic Surgical System. The....
5 Must-Read Quotes for Robotic Surgery Investors
Something big just happened in the robotic surgical industry. Last week, a small company called TransEnterix (NYSEMKT: TRXC) won FDA approval for its Senhance Robotic Surgical System. The....
5 Must-Read Quotes for Robotic Surgery Investors
Something big just happened in the robotic surgical industry. Last week, a small company called TransEnterix (NYSEMKT: TRXC) won FDA approval for its Senhance Robotic Surgical System. The....
This Marijuana Stock Could Be the Biggest Comeback Story of 2018
Insys Therapeutics (NASDAQ: INSY) is one of the most hated biotech stocks on the market today. That's the case, at least, if you use short interest as a proxy for how much investors hate a given....
Should You Avoid Celgene Stock After Its Big Pipeline Setback?
Even some of the biggest and best have things go wrong every now and then. Celgene (NASDAQ: CELG) has been the best-performing biotech stock over the last five years among big biotechs with market....
5 Key Drugs Critical to Johnson & Johnson's Future
Johnson & Johnson (NYSE: JNJ) recently shared its third-quarter financial report card with investors, and by all measures, it deserves kudos. However, the stock market rewards investors based....
5 Key Drugs Critical to Johnson & Johnson's Future
Johnson & Johnson (NYSE: JNJ) recently shared its third-quarter financial report card with investors, and by all measures, it deserves kudos. However, the stock market rewards investors based....
Robots Power Profits at Intuitive Surgical
Intuitive Surgical (NASDAQ: ISRG) recently provided investors with its third-quarter financial report card, and the company delivered high marks for system placements and sales and procedure....
Robots Power Profits at Intuitive Surgical
Intuitive Surgical (NASDAQ: ISRG) recently provided investors with its third-quarter financial report card, and the company delivered high marks for system placements and sales and procedure....
Robots Power Profits at Intuitive Surgical
Intuitive Surgical (NASDAQ: ISRG) recently provided investors with its third-quarter financial report card, and the company delivered high marks for system placements and sales and procedure....
Legalizing Recreational Marijuana in Colorado Reversed a 14-Year Trend of Rising Opioid-Related Deaths
The marijuana industry is, for lack of a better pun, sprouting like a weed. According to cannabis research firm ArcView, the North American legal weed market grew by 34% in 2016 and is expected to....
Better Buy: Exelixis, Inc. vs. Intra-Cellular Therapies Inc.
Biotech investors are always looking for the next big thing. That's exactly what they found in Exelixis (NASDAQ: EXEL), which ranked as one of the top biotech stocks of 2016 (and 2015 also). But....
3 Stocks That Turned $3,000 Into $7,300 or More So Far in 2017
If you have just $3,000 to invest, that's a good foundation upon which to start building your portfolio. But resist the urge to bet it all on just one stock. Diversifying your holdings, even when....
3 Healthcare Stocks That Soared This Week: Are They Buys?
It's stunning just how much healthcare stocks can move in only a matter of five days. For three healthcare stocks, the past week was especially fantastic thanks to major catalysts.TransEnterix....
With Lots of Moving Pieces, Intuitive Surgical, Inc. Reports Yet Another Strong Quarter
Intuitive Surgical (NASDAQ: ISRG) shareholders like myself have gotten spoiled. After some lean years following the onset of the Affordable Care Act and the concurrent tightening of hospitals'....
With Lots of Moving Pieces, Intuitive Surgical, Inc. Reports Yet Another Strong Quarter
Intuitive Surgical (NASDAQ: ISRG) shareholders like myself have gotten spoiled. After some lean years following the onset of the Affordable Care Act and the concurrent tightening of hospitals'....
With Lots of Moving Pieces, Intuitive Surgical, Inc. Reports Yet Another Strong Quarter
Intuitive Surgical (NASDAQ: ISRG) shareholders like myself have gotten spoiled. After some lean years following the onset of the Affordable Care Act and the concurrent tightening of hospitals'....
Intuitive Surgical Continues Its Strong Growth
Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in robotic-assisted surgery, announced the results of its just-completed third quarter after the market closed on Thursday. The company reported....
Intuitive Surgical Continues Its Strong Growth
Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in robotic-assisted surgery, announced the results of its just-completed third quarter after the market closed on Thursday. The company reported....
Intuitive Surgical Continues Its Strong Growth
Intuitive Surgical, Inc. (NASDAQ: ISRG), the leader in robotic-assisted surgery, announced the results of its just-completed third quarter after the market closed on Thursday. The company reported....
How Big of a Deal Is Celgene's Flop?
Celgene (NASDAQ: CELG) shuttered two GED-301 Crohn's disease trials this week after an interim look at data by independent monitors proved disappointing. The late-stage failure dings Celgene's....
Why uniQure N.V. Stock Is Hopping Today
Shares of the gene therapy company uniQure N.V. (NASDAQ: QURE) rose by as much as 27% in early-morning trading today on over 27 times the average volume. uniQure's stock is responding positively....
Why Celgene Corporation Dropped Today
Celgene (NASDAQ: CELG) is down 10.2% at 12:09 p.m. Friday after announcing yesterday after the market closed that it was stopping a clinical trial testing GED-0301 (mongersen) in Crohn's disease....